GlaxoSmithKline Pharmaceuticals Overview
- Status
- Public
- Employees
- 4,364

- Stock Symbol
- 500660

- Investments
- 2
- Share Price
- $20.40
- (As of Monday Closing)
GlaxoSmithKline Pharmaceuticals General Information
Description
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.
Contact Information
- Mumbai
- India
GlaxoSmithKline Pharmaceuticals Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$20.40 | $20.81 | $13.88 - $24.51 | $3.46B | 169M | 3.29K | -$0.27 |
GlaxoSmithKline Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
---|---|---|---|---|
EV | 3,598,766 | 2,665,745 | 2,972,013 | 2,698,465 |
Revenue | 418,266 | 453,815 | 446,922 | 445,384 |
EBITDA | (18,140) | 44,836 | 93,515 | 81,516 |
Net Income | (45,566) | 13,118 | 63,634 | 54,400 |
Total Assets | 369,576 | 415,744 | 563,190 | 606,333 |
Total Debt | 5,937 | 5,548 | 84 | 152 |
GlaxoSmithKline Pharmaceuticals Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
0. 00000000 | Self | Board Member | 000 0000 |
00000 000000000 | Self | Independent and Non-Executive Director | 000 0000 |
GlaxoSmithKline Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGlaxoSmithKline Pharmaceuticals Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 | 16-Jul-2015 | 00000 00000 00 | 00000 | Biotechnology | |
Silarus Therapeutics | 22-Sep-2014 | Early Stage VC | 0000 | Drug Discovery |